These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 18249480

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation.
    Caffarel MM, Sarrió D, Palacios J, Guzmán M, Sánchez C.
    Cancer Res; 2006 Jul 01; 66(13):6615-21. PubMed ID: 16818634
    [Abstract] [Full Text] [Related]

  • 5. Role of cannabinoid receptors in Delta-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila.
    Lu T, Newton C, Perkins I, Friedman H, Klein TW.
    Eur J Pharmacol; 2006 Feb 17; 532(1-2):170-7. PubMed ID: 16443217
    [Abstract] [Full Text] [Related]

  • 6. Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol.
    Buchweitz JP, Karmaus PW, Williams KJ, Harkema JR, Kaminski NE.
    J Leukoc Biol; 2008 Mar 17; 83(3):785-96. PubMed ID: 18073275
    [Abstract] [Full Text] [Related]

  • 7. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
    Rao GK, Kaminski NE.
    J Pharmacol Exp Ther; 2006 May 17; 317(2):820-9. PubMed ID: 16436496
    [Abstract] [Full Text] [Related]

  • 8. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
    Wilkinson JD, Williamson EM.
    J Dermatol Sci; 2007 Feb 17; 45(2):87-92. PubMed ID: 17157480
    [Abstract] [Full Text] [Related]

  • 9. Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo.
    Preet A, Ganju RK, Groopman JE.
    Oncogene; 2008 Jan 10; 27(3):339-46. PubMed ID: 17621270
    [Abstract] [Full Text] [Related]

  • 10. Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways.
    Verhoeckx KC, Korthout HA, van Meeteren-Kreikamp AP, Ehlert KA, Wang M, van der Greef J, Rodenburg RJ, Witkamp RF.
    Int Immunopharmacol; 2006 Apr 10; 6(4):656-65. PubMed ID: 16504929
    [Abstract] [Full Text] [Related]

  • 11. Cannabinoid receptors in conjunctival epithelium: identification and functional properties.
    Iribarne M, Torbidoni V, Julián K, Prestifilippo JP, Sinha D, Rettori V, Berra A, Suburo AM.
    Invest Ophthalmol Vis Sci; 2008 Oct 10; 49(10):4535-44. PubMed ID: 18566465
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.
    Galanti G, Fisher T, Kventsel I, Shoham J, Gallily R, Mechoulam R, Lavie G, Amariglio N, Rechavi G, Toren A.
    Acta Oncol; 2008 Oct 10; 47(6):1062-70. PubMed ID: 17934890
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K, Mishima K, Hazekawa M, Sano K, Irie K, Orito K, Egawa T, Kitamura Y, Uchida N, Nishimura R, Egashira N, Iwasaki K, Fujiwara M.
    Brain Res; 2008 Jan 10; 1188():157-64. PubMed ID: 18021759
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
    Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V.
    J Pharmacol Exp Ther; 2006 Sep 10; 318(3):1375-87. PubMed ID: 16728591
    [Abstract] [Full Text] [Related]

  • 18. Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids.
    Papahatjis DP, Nahmias VR, Andreou T, Fan P, Makriyannis A.
    Bioorg Med Chem Lett; 2006 Mar 15; 16(6):1616-20. PubMed ID: 16387492
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.